Definition

A drug-economics structure mapped onto transactional consulting and vendor relationships. The tactic produces a real bump — the hit is real — but the bump does not fix the operating model, it makes the next tactic necessary. Tolerance builds: each tactic has to be sharper to produce the same bump, and the operator escalates from advice to systems to programs to certifications, chasing the original feeling. Withdrawal is worse than the original problem — the operator who tries to quit the cycle hits a crash that feels like business collapse, when actually the business is finally surfacing what was true the whole time. The pusher pretends to be a friend; both sides make money from the dependency, not the cure. Desperate buyers are the best customers — operators in crisis pay anything for relief.

Explanation

The tell is an operator who can name every consultant they have worked with but cannot name their own operating model. That’s not a coincidence — it’s the mechanism working as designed. Every purchase relieves the symptom enough to avoid the harder work of building [Meaningfully Differentiated Value], which is exactly why the next purchase is always waiting.

This is a Road 1 mechanism dressed in Road 2 language — sold as partnership, relationship, transformation, while the actual economics run on repeat crisis-driven purchase. The way out isn’t a better program. It’s the operator naming what they’re actually buying and building the thing programs were supposed to produce in the first place.